Opgn stock forecast.

The value each OPGN share was expected to gain vs. the value that each OPGN share actually gained. OpGen (OPGN) reported Q3 2023 earnings per share (EPS) of-$0.46, missing estimates of -$0.43 by 7.63%. In the same quarter last year, OpGen's earnings per share (EPS) was-$5.92.Investors and traders typically interpret a stock price target as a forecast for a future price for the respective stock. For example, if an analyst sets a target price that is higher than the ...WebFind the latest OpGen, Inc. (OPGN) stock quote, history, news and other vital information to help you with your stock trading and investing. OpGen Stock Price, News & Analysis (NASDAQ:OPGN) $0.44 -0.02 (-3.34%) (As of 12:22 PM ET) Compare Today's Range $0.43 $0.47 50-Day Range $0.20 $1.19 52-Week Range $0.17 $9.05 Volume 105,087 shs Average Volume 1.54 million shs Market Capitalization $4.46 million P/E Ratio N/A Dividend Yield N/A Price Target N/A Stock Price Forecast. According to 5 stock analysts, the average 12-month stock price forecast for Nkarta stock is $13, which predicts an increase of 392.42%. The lowest target is $9.00 and the highest is $18. On average, analysts rate Nkarta stock as a strong buy.

14 de set. de 2021 ... With these developments, bullish analysts, and underlying industry momentum, OPGN stock has managed to push higher this month.

Sep-16-21 09:03AM. 4 Penny Stocks Insiders Are Buying. (Benzinga) OpGen, Inc. is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. It engages in the development of molecular information products and services for global healthcare settings.Web

View the latest OPGN earnings date, analysts forecasts, earnings history, and conference call transcripts. Skip to main content. S&P 500 4,594.63 (+0.59%) DOW 36,245.50 (+0.82%) QQQ 389.94 (+0.29%) AAPL 191.24 (+0.68%) MSFT 374.51 (-1.16%) META 324.82 (-0.71%) ... Compare your portfolio performance to leading indices and get …52-Week Range. 0.165 - 9.060. -0.81. Analysts. n/a. Earnings Date. Nov 14, 2023. About OPGN. OpGen, Inc., a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally.For OpGen stock forecast for 2031, 12 predictions are offered for each month of 2031 with average OpGen stock forecast of $0.24, a high forecast of $0.25, and a low forecast of $0.22. The average OpGen stock forecast 2031 represents a -47.69% decrease from the last price of $0.455000013113022. For OpGen stock forecast for …Discover historical prices for OPGN stock on Yahoo Finance. View daily, weekly or monthly format back to when OpGen, Inc. stock was issued. ... OpGen, Inc. (OPGN) NasdaqCM - NasdaqCM Real Time ...OpGen, Inc. (Gaithersburg, MD, USA) (Nasdaq OPGN) is a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to guide clinicians with rapid and actionable information about life-threatening infections to improve patient outcomes and decrease the spread of infections caused by multidrug-resistant ...Web

Long term indicators fully support a continuation of the trend. OpGen, Inc. is a microbial genetics analysis company. The Company offers optical mapping services for analysis of microbial, yeast and fungal genomic architecture. OpGen, Inc. headquartered in Gaithersburg, Maryland. minute delay (Cboe BZX is real-time), ET.

Find the latest OpGen, Inc. (OPGN) stock quote, history, news and other vital information to help you with your stock trading and investing.

On May 2, 2023, OpGen announced that it had successfully priced an offering of shares and warrants, raising $3.5 millionSep-16-21 09:03AM. 4 Penny Stocks Insiders Are Buying. (Benzinga) OpGen, Inc. is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. It engages in the development of molecular information products and services for global healthcare settings.WebOutlook: OpGen Inc. Common Stock is assigned short-term Ba1 & long-term Ba1 estimated rating. Dominant Strategy : Wait until speculative trend diminishes Time series to forecast n: 17 May 2023 for (n+8 weeks) Methodology : Multi-Instance Learning (ML)Nasdaq | OPGN U.S.: Nasdaq OpGen Inc. Watch list NEW Set a price target alert Closed Last Updated: Nov 27, 2023 4:00 p.m. EST Real time quote $ 0.4604 0.0054 1.19% Previous Close $0.4550 Advanced... Nov 17, 2023 · How much is Opgen stock worth today? ( NASDAQ: OPGN) Opgen currently has 10,013,524 outstanding shares. With Opgen stock trading at $0.46 per share, the total value of Opgen stock (market capitalization) is $4.59M. Opgen stock was originally listed at a price of $48,500.00 in May 5, 2015.

See OpGen, Inc. (OPGN) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Find the latest Earnings Report Date for OpGen, Inc. Common Stock (OPGN) at Nasdaq.com.Long term indicators fully support a continuation of the trend. OpGen, Inc. is a microbial genetics analysis company. The Company offers optical mapping services for analysis of microbial, yeast and fungal genomic architecture. OpGen, Inc. headquartered in Gaithersburg, Maryland. minute delay (Cboe BZX is real-time), ET.Oct 5, 2021 · For OpGen stock forecast for 2031, 12 predictions are offered for each month of 2031 with average OpGen stock forecast of $0.24, a high forecast of $0.25, and a low forecast of $0.22. The average OpGen stock forecast 2031 represents a -47.69% decrease from the last price of $0.455000013113022. For OpGen stock forecast for 2033 (10 year), 11 ... Nov 17, 2023 · How much is Opgen stock worth today? ( NASDAQ: OPGN) Opgen currently has 10,013,524 outstanding shares. With Opgen stock trading at $0.46 per share, the total value of Opgen stock (market capitalization) is $4.59M. Opgen stock was originally listed at a price of $48,500.00 in May 5, 2015.

159.53. -1.48%. 3.08M. Find the latest OpGen Inc (OPGN) stock forecast, 12-month price target, predictions and analyst recommendations.

See OpGen, Inc. (OPGN) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.DM Stock 12 Months Forecast. $1.00. (27.88% Upside) Based on 2 Wall Street analysts offering 12 month price targets for Desktop Metal in the last 3 months. The average price target is $1.00 with a high forecast of $1.00 and a low forecast of $1.00. The average price target represents a 27.88% change from the last price of $0.78. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these ...Stock Price Forecast. The 1 analysts offering 12-month price forecasts for MyMD Pharmaceuticals Inc have a median target of 1,536.00, with a high estimate of 1,536.00 and a low estimate of 1,536.00.Find the latest Spok Holdings, Inc. (SPOK) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W ...WebFind the latest OpGen, Inc. (OPGN) stock quote, history, news and other vital information to help you with your stock trading and investing.Check out our OCGN stock analysis, current OCGN quote, charts, and historical prices for Ocugen Inc stockWeb52-Week Range. 0.165 - 9.060. -0.81. Analysts. n/a. Earnings Date. Nov 14, 2023. About OPGN. OpGen, Inc., a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally.Find the latest Phio Pharmaceuticals Corp. (PHIO) stock quote, history, news and other vital information to help you with your stock trading and investing.

$0.400 -0.0147 (-3.54%) At Close: Dec 01, 2023 Real-time prices appear during market hours U.S. markets are closed | Score: -4.75 Strong Sell Hold Strong Buy …

NASDAQ: OPGN · IEX Real-Time Price · USD. Add to Watchlist 0.460 +0.005 (1.12%) ... OpGen Stock Forecast. All Analysts Top Analysts Stock Price Forecast.

NASDAQ: OPGN · IEX Real-Time Price · USD. Add to Watchlist 0.460 +0.005 (1.12%) ... OpGen Stock Forecast. All Analysts Top Analysts Stock Price Forecast.Bollinger Bands charts for OPGN (OpGen, Inc.). Bollinger Bands consist of a set of three curves drawn in relation to securities prices.Find the latest OpGen, Inc. (OPGN) stock quote, history, news and other vital information to help you with your stock trading and investing.Oct 14, 2023 · OpGen, Inc. (OPGN) share price prediction for 2023, 2024, 2025, 2026 and 2027. OPGN one year forecast. Opgen stock monthly and weekly forecasts. Find the latest Tivic Health Systems, Inc. (TIVC) stock quote, history, news and other vital information to help you with your stock trading and investing.The Reverse Stock Split will become effective at 12:01 a.m. EST, on January 5, 2023 and the Company’s common stock will open for trading on The Nasdaq Capital Market on a post-split basis under ...Last reporting date. November 22, 2023. EPS forecast (this quarter) -$0.86. Annual revenue (last year) $0.00. Annual profit (last year) -$14.6M. Net profit margin.DM Stock 12 Months Forecast. $1.00. (27.88% Upside) Based on 2 Wall Street analysts offering 12 month price targets for Desktop Metal in the last 3 months. The average price target is $1.00 with a high forecast of $1.00 and a low forecast of $1.00. The average price target represents a 27.88% change from the last price of $0.78.Federal Realty Investment Trust stock falls Tuesday, underperforms market. Stifel Settles With Massachusetts Over Alleged Lax Broker SupervisionWeb1 analysts have issued 1-year target prices for Tonix Pharmaceuticals' stock. Their TNXP share price targets range from $8.00 to $8.00. On average, they anticipate the company's share price to reach $8.00 in the next twelve months. This suggests a possible upside of 1,547.8% from the stock's current price.Are you tired of spending countless hours manually tracking your inventory? Are you looking for a way to improve your decision making and forecasting processes? Look no further than a free inventory tracking template.OPI stock forecast for 2023 – 2027. Last updated: February 25, 2023. OPI. Office Properties Income Trust. 16.94 D 1.28% (0.22) Are you interested in Office Properties Income Trust stocks prediction? If yes, then on this page you will find useful information about the dynamics of the OPI stock price in 2022-2027. Is OPI a good long term stock?

According to the National Snow & Ice Data Center, blizzard prediction relies on modeling weather systems, as well as predicting temperatures. The heavy snowfall that blizzards create can be hard to predict in advance.-84.51% Year-to-Date Quote Profile News Charts Forecasts Financials Shareholders Competitors vs. Commercial Services News Chart Latest OPGN News | Press Releases No recent news for OpGen Inc....Oct 12, 2023 · Together we improve patient care and fight AMR through cutting edge molecular microbiology. OpGen, along with its subsidiaries, Curetis and Ares Genetics, develop and commercialize molecular microbiology solutions to help guide clinicians with more rapid and actionable information about life threatening infections to improve patient outcomes. Instagram:https://instagram. titan cementexxon dividend historybulls on wallstreetbill.com news Stock Price Forecast. The 1 analysts offering 12-month price forecasts for MyMD Pharmaceuticals Inc have a median target of 1,536.00, with a high estimate of 1,536.00 and a low estimate of 1,536.00. jet.ai stocktenant health On May 2, 2023, OpGen announced that it had successfully priced an offering of shares and warrants, raising $3.5 million vanguard international bond fund It's typically categorized as a valuation metric and is most often quoted as Cash Flow per Share and as a Price to Cash flow ratio. In this case, it's the cash flow growth that's being looked at ...Opgen Inc (OPGN) Stock Price Today, Quote, Latest Discussions, Interactive Chart and News Advertisement 3rd Party Ad. Not an offer or recommendation by Stocktwits. See …Find the latest OpGen, Inc. (OPGN) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.